With more than 25 years' experience counselling clients in Europe, Australia and across Asia Pacific, Sue has expertise in healthcare, pharmaceuticals, biotechnology, food and nutrition, corporate communications and crisis and issues management.
Sue has led communications programs to support health promotion; health policy change, market preparation, product launches and rescheduling for ethical and OTC pharmaceuticals, vaccines and health devices; product withdrawals and liability issues; crisis and issues management; and has provided stakeholder and health issues counsel for the food sector.
Sue was most recently Managing Director, Healthcare at Hill+Knowlton Strategies London for more than two years where she was responsible for business strategy, marketing, new business development, client service, team culture and professional development. She provided senior counsel to clients such as Shire, Gilead, Novartis, Lundbeck and Roche.
Sue transferred to H+K London from H+K Australia where she was Managing Director for two years. Prior to this she was the Asia Pacific Health Practice Director for H+K, providing strategic direction on healthcare work undertaken by its offices in the region, overseeing pan Asian programs and working closely with the global health practice. Her work for an Australian biotechnology company was recognised with two industry awards for corporate communications, and subsequently after its acquisition by LEO Pharma, three awards for disease awareness.
Prior to entering public relations Sue was the national medical writer on The Australian for four years and was founding Vice President of The Australian Medical Writers' Association.
Sue is a graduate of The Royal Melbourne Institute of Technology's Diploma of Arts (Journalism). She served on the organising committee for the Australian Pharmaceutical Research, Innovation & Marketing Excellence Awards. She was a judge on the 2012 Asia Pacific SABRE Awards and the 2012 B&T Awards.